David earned a PhD in Biological Sciences from Columbia University in New York, NY, where he studied how Drosophila ovarian adult stem cells respond to cell signaling pathway manipulations. This work helped to redefine the organizational principles underlying adult stem cell growth models. He is currently a Science Writer, as part of the BioNews Services writing team.
The first healthy volunteer has been dosed in an Australian Phase 1 clinical trial investigating IMU-856, a potential novel treatment for inflammatory bowel disease (IBD), according to the therapy’s developer Immunic ... Read more
The European Commission has approved an under-the-skin injectable formulation of Remsima (infliximab) to treat patients with the two most common forms of inflammatory bowel disease (IBD) — ulcerative colitis and ... Read more
People who have been previously diagnosed with either celiac disease or inflammatory bowel disease (IBD) have an increased risk of being diagnosed with the other illness, according to new research. ... Read more
The Bruce and Cynthia Sherman Charitable Foundation is now accepting nominations for the 2020 Sherman Prizes, which recognize individuals working toward improving the lives of people with Crohn’s disease and ... Read more
The U.K. National Institute for Health and Care Excellence (NICE) has recommended the use of Stelara (ustekinumab) to treat patients with moderately to severely active ulcerative colitis specifically in adults when ... Read more